Image

Evaluation of Neoplasia With Artificial Intelligence in Gastrointestinal Endoscopy

Evaluation of Neoplasia With Artificial Intelligence in Gastrointestinal Endoscopy

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study aims to validate and evaluate AI algorithms for detection and characterization of early GI neoplasia.

Description

This is an investigator initiated; multi-centre study and will be conducted in two phases. Validation & Optimization phase, where routinely collected and anonymized endoscopic images and videos from the departmental teaching and training library will be used to validate, and if needed fine-tune and improve, the accuracy of an AI algorithm. Testing phase, where the evaluation of AI algorithms performance will be conducted on a prospective basis. The ground truth (standard) will be expert assessment and histological diagnosis.

This study has no direct impact on patient's clinical care, and collection of all endoscopic data will take place during standard endoscopy procedures done for purely clinical indications. No additional procedures, biopsies or interventions will be performed as a part of this study.

Eligibility

Inclusion Criteria:

        -The participant must meet ALL of the following criteria to be considered eligible for the
        study:
          -  Male or Female, aged 18 years or above.
          -  Requiring gastroscopy and/or colonoscopy to investigate gastrointestinal symptoms, or
             as part of screening or ongoing surveillance of GI neoplasia.
          -  Participant is willing and able to give informed consent for participation in the
             study.
        Exclusion Criteria
        The participant may not enter the study if ANY of the following apply:
          -  Patients with endoscopically active severe oesophagitis
          -  Poor bowel preparation

Study details
    Gastrointestinal Neoplasms

NCT04937647

Portsmouth Hospitals NHS Trust

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.